DH ENCHANTMENT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0021 USD | +5.00% |
|
+50.00% | -8.70% |
| Sales 2023 | 15.1K 20.76K | Sales 2024 | 686 943.35 | Capitalization | 831K 1.14M |
|---|---|---|---|---|---|
| Net income 2023 | - 0 | Net income 2024 | - 0 | EV / Sales 2023 | 300 x |
| Net Debt 2023 | 283K 389K | Net Debt 2024 | 409K 563K | EV / Sales 2024 | 1,809 x |
| P/E ratio 2023 |
-11
x | P/E ratio 2024 |
-5.35
x | Employees | 3 |
| Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 13.39% |
More Fundamentals
* Assessed data
More press releases
| 1 day | +5.00% | ||
| 1 week | +50.00% | ||
| Current month | +5.00% | ||
| 1 month | +50.00% | ||
| 3 months | +110.00% | ||
| 6 months | -8.70% | ||
| Current year | -8.70% |
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.00
1 year
0.000.01
3 years
0.000.89
5 years
0.000.89
10 years
0.000.89
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-01 | 0.0021 | +5.00% | 4,000 |
| 24-06-28 | 0.002 | -54.55% | 9,500 |
Delayed Quote OTC Markets, July 01, 2024 at 11:09 am
More quotes
DH Enchantment, Inc. is a holding company. The Company conducts its operations through its Hong Kong subsidiary, Ho Shun Yi Limited (HSY). HSY is engaged primarily in the sale and distribution of Coronavirus Disease 2019 (COVID-19) rapid antigen tester sets produced by third parties. HSY primarily sells its products primarily in Hong Kong. HSY's wholly owned subsidiary is DH Investment Group Limited, which is an investment holding company. The Company operates its testing business through DH Investment Group Limited.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -8.70% | 1.75M | |
| +56.86% | 823B | |
| +43.90% | 641B | |
| -6.57% | 352B | |
| +17.32% | 324B | |
| +9.94% | 301B | |
| +16.08% | 241B | |
| +2.29% | 223B | |
| +13.96% | 218B | |
| +7.98% | 167B |
- Stock Market
- Equities
- ENMI Stock
